211 results on '"Peyton, Charles"'
Search Results
2. Intravascular Ultrasound for the Evaluation and Management of Retroperitoneal, Genitourinary Malignancies
3. PD18-04 SURVIVAL IS DRAMATICALLY IMPROVED FOR MRCC PATIENTS WITH SARCOMATOID FEATURES WHO ARE TREATED WITH CYTOREDUCTIVE NEPHRECTOMY AND IMMUNE CHECKPOINT INHIBITORS REGARDLESS OF TREATMENT SEQUENCE
4. PD18-07 RISK FACTORS FOR PROGRESSION AND SURVIVAL IN MRCC PATIENTS WITH NO EVIDENCE OF DISEASE FOLLOWING CYTOREDUCTIVE NEPHRECTOMY WITH METASTASES DIRECTED THERAPY
5. MP61-13 UTILITY OF ctDNA FOR MONITORING TREATMENT RESPONSE IN PENILE AND PRIMARY URETHRAL CANCERS
6. MP15-19 DETERMINING THE GENETIC CAUSES OF BLADDER CANCER IN A FAMILY WITH A HERITABLE PATTERN OF BLADDER CANCER
7. PD18-06 VALIDATION OF THE SELECTION FOR CYTOREDUCTIVE NEPHRECTOMY (SCREEN) MODEL USING AN INDEPENDENT CONTEMPORARY MULTI-CENTER COHORT
8. PD18-08 TUMOR SIZE REDUCTION (≥10%) RESULTING FROM PRE-SURGICAL SYSTEMIC THERAPY PREDICTS IMPROVED SURVIVAL FOLLOWING CYTOREDUCTIVE NEPHRECTOMY
9. Postoperative Outcomes and Analgesic Requirements of Single-Port vs Multiport Robotic-Assisted Radical Cystectomy
10. Regional Therapy of Bladder Tumors
11. Retroperitoneal Lymph Node Dissection Versus Surveillance for Adult Early Stage Pure Testicular Teratoma: A Nationwide Analysis
12. The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy
13. Editorial Comment
14. Are markers of survival associated with perioperative outcomes for tumor thrombectomy patients?
15. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Penile Squamous Cell Carcinoma Patients Undergoing Inguinal Lymph Node Dissection
16. Impact of PI3K-AKT-mTOR Signaling Pathway Up-regulation on Prognosis of Penile Squamous-Cell Carcinoma: Results From a Tissue Microarray Study and Review of the Literature
17. Solitary fibrous tumours involving the genitourinary tract: a case series in rare locations, highlighting the role of STAT6 immunohistochemistry
18. Regional Therapy of Bladder Tumors
19. Survival Outcomes Associated With Female Primary Urethral Carcinoma: Review of a Single Institutional Experience
20. Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration
21. National Trends and Predictors of Locally Advanced Penile Cancer in the United States (1998-2012)
22. Estimating Minimally Important Differences for the Bladder Cancer Index Using Distribution- and Anchor-Based Approaches
23. Updates on the use of intravesical therapies for non-muscle invasive bladder cancer: how, when and what
24. Bone Preservation Strategies for Men on Androgen Deprivation Therapy
25. Performance of a tumor-informed molecular residual disease (MRD) assay in resected bladder cancer with mixed or pure variant histology: Analysis of a real-world multicenter cohort.
26. Optimal Management of Upper Tract Urothelial Carcinoma: an Unmet Need
27. Longitudinal detection of circulating tumor DNA in patients with advanced renal cell carcinoma.
28. Intravenous caval leiomyomatosis in the setting of renal cell carcinoma – A case report
29. Comparative analysis of three vs. four cycles of neoadjuvant gemcitabine and cisplatin for muscle invasive bladder cancer
30. Erectile Dysfunction is Predictive of Endothelial Dysfunction in a Well Visit Population
31. MP43-03 ENDOTHELIAL DYSFUNCTION DETECTED BY PERIPHERAL ARTERIAL TONOMETRY IS MORE PREVALENT IN MEN WITH ERECTILE DYSFUNCTION
32. Reply By Authors
33. Pathological and Survival Outcomes Associated with Variant Histology Bladder Cancers Managed by Cystectomy with or without Neoadjuvant Chemotherapy
34. Patterns of Initial Metastatic Recurrence After Surgery for High-Risk Nonmetastatic Renal Cell Carcinoma
35. Prophylactic Effect of Tadalafil on Bladder Function in a Rat Model of Chronic Bladder Ischemia
36. Systematic Review and Meta-Analysis—Is there a Benefit in Using Neoadjuvant Systemic Chemotherapy for Locally Advanced Penile Squamous Cell Carcinoma?
37. Reply by Authors
38. PD11-08 PARTIAL NEPHRECTOMY IS NOT ASSOCIATED WITH RECURRENCE IN SELECTED HIGH RISK RENAL CELL CARCINOMA PATIENTS
39. Current management and management controversies in early- and intermediate-stage of nonseminoma germ cell tumors
40. Therapeutic strategies for uncommon testis cancer histologies: teratoma with malignant transformation and malignant testicular sex cord stromal tumors
41. Primary tumor size thresholds in stage IA testicular seminoma: Implications for adjuvant therapy after orchiectomy and survival
42. Identifying and Codifying Complications after Radical Cystectomy: Comparison of Administrative Diagnostic and Procedure Codes, and Clinical Chart Review
43. Abstract 4902: Positive Ki-67 expression in post neoadjuvant chemotherapy (NAC) radical cystectomy samples are associated with lack of tumor downstaging and shorter overall survival (OS) in patients with muscle invasive bladder cancer (MIBC)
44. MP05-11 RECOVERY OF PATIENT-REPORTED FUNCTION, BODY IMAGE AND GENERAL HEALTH AFTER CYSTECTOMY AND URINARY DIVERSION
45. PD46-08 EARLY RECURRENCE PATTERNS SHOULD INFORM SURVEILLANCE PROTOCOLS FOLLOWING SURGERY FOR HIGH RISK NON-METASTATIC RENAL CELL CARCINOMA
46. MP49-10 PROGNOSTICATORS OF INGUINAL LYMPH NODE METASTASIS AND SURVIVAL IN CLINICAL NODE-NEGATIVE PENILE SQUAMOUS CELL CARCINOMA PATIENTS
47. MP38-05 EVOLUTION OF THE DIAGNOSIS OF THE MICROPAPILLARY VARIANT OF UROTHELIAL CARCINOMA OVER TIME
48. Estimating Minimally Important Differences for the Bladder Cancer Index Using Distribution and Anchor Based Approaches
49. MP49-14 PRIMARY TUMOR SIZE THRESHOLDS IN STAGE IA TESTICULAR SEMINOMA: IMPLICATIONS FOR ADJUVANT THERAPY AFTER ORCHIECTOMY AND SURVIVAL
50. MP38-08 OUTCOMES ASSOCIATED WITH MIXED AND VARIANT HISTOLOGY TREATED WITH CHEMOTHERAPY PRIOR TO CYSTECTOMY AND CYSTECTOMY ALONE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.